FDA-cleared AI app for point-of-care diagnosis of heart failure launched
Exo announced the launch of its FDA-cleared AI imaging applications for the diagnosis of heart failure on its handheld ultrasound device.The AI app (Exo Iris) is designed to improve point-of-care access to timely HF diagnosis, particularly in rural and under-resourced settings, according to a press release from the company.